glp 1 and type 1 diabetes GLP-1-based therapies for 2 diabetes: from single, dual triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Clinical Focus on GLP-1 Agonists

2025 Nov 17

Weight-Based Dosing Considerations Under 150 lbs : 200-300 mcg daily 150-200 lbs : 300-400 mcg daily (standard protocol) Over 200 lbs : 400-500 mcg daily Athletes/High Activity : May require upper range dosing regardless of weight Administration and Injection Guidelines Injection Methods BPC-157 can be administered subcutaneously or intramuscularly, with subcutaneous being most common for systemic healing effects

Before Bed : The most common timing for GHSs, as it synchronizes with the body's natural nocturnal GH pulse, maximizing the anabolic and restorative effects during sleep

Stable glucose levels help reduce cravings, making it easier to control eating habits and maintain consistent energy

After four years on the drug, participants had kept an average of 10.2 percent of their starting weight off (4)

Overview of Epitalon Highly Bioactive Pineal Tetrapeptide with Promising Properties International Journal of Molecular Sciences Comprehensive review detailing 25 years of epitalon research including telomerase activation mechanisms, methylated DNA binding, histone H1 interaction, and epigenetic regulation of gene expression